- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02846597
Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants
Sustained Lung Inflation at Birth for Preterm Infants at Risk of Respiratory Distress Syndrome: the Proper Pressure and Duration: Prospective Randomized Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be a randomized prospective pilot study in Mansoura University Hospital then the cases were followed at Neonatal Intensive Care Unit in Mansoura University Children Hospital, Mansoura, Egypt.
Preterm infants born equal to or less than 32 weeks gestation with respiratory distress syndrome will be included in the study.
We aim to study the proper pressure and duration of sustained lung inflation in the delivery room.
Preterm infants will be divided into 5 groups:
- Group 1 (Control group). In this group preterm infants will not be treated with sustained lung inflation and in stead will receive regular respiratory care
- Group 2 (High pressure for long duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 20 cm H2O for 20 seconds
- Group 3 (High pressure for short duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 20 cm H2O for 10 seconds.
- Group 4 (Low pressure for long duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 15 cm H2O for 20 seconds.
- Group 5 (Low pressure for short duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 15 cm H2O for 10 seconds
Sustained lung inflation will be delivered using the T - piece ventilator (Neopuff infant resuscitator; Fisher & Paykel, Auckland, New Zealand ).
All preterm infants with respiratory distress will follow the following steps for neonatal resuscitation
- All infants will receive initial care including providing warmth, clearing the airway, and drying and stimulating the infant.
- After the initial steps, pulse oximetry will be initiated to determine oxygen saturation and to guide the required FIO2.
- Infants in the intervention groups will receive a single single maneuver of sustained lung inflation with the first breath according to the study group.
- Continuous positive airway pressure at a pressure of 5 cm H2O and FIO2 of 30% will be delivered to infants in the control group immediately after initial steps of resuscitation and to all infants in the intervention groups after the single maneuver of sustained lung inflation.
- Positive pressure ventilation will be provided uring the T-piece resuscitator if the infant has an inadequate respiratory effort or a heart rate <100 beats per minute at a rate of 40 to 60 times per minute for 30 seconds, after which the heart rate is measured.
- Oxygen therapy will be titrated to keep a pre-ductal saturation between 90-95%.
- Endotracheal intubation will be provided if positive pressure ventilation is ineffective, prolonged apnea, or chest compression is required.
- Chest compression will be required if the infant's heart rate remains <60 bpm despite adequate ventilation for 30 seconds.
- Surfactant will be administered to preterm infants requiring a fraction of inspired oxygen of 40 percent or higher to maintain oxygen saturation above 90 percent or remain apneic.
- Mechanical ventilation will be initiated for preterm infants with respiratory acidosis documented by an arterial pH <7.2 and PaCO2 >60 to 65 mmHg, hypoxia documented by an arterial PaO2 <50 mmHg despite FiO2 exceeds 40 percent on nasal continuous positive airway pressure, or severe apnea.
The primary outcome of the study will be the need for endotracheal intubation in the delivery room.
Secondary outcomes include the need for surfactant therapy, the need for endotracheal intubation and mechanical ventilation within 72 hours of birth, the duration of mechanical ventilation and oxygen support, development of air leak syndromes, length of hospital stay, bronchopulmonary dysplasia, necrotising enterocolitis, intraventricular haemorrhage, retinopathy of prematurity, and neonatal mortality before hospital discharge,.
Broncho alveolar lavage will be performed to endotracheally intubated infants enrolled in this study to measure the level of IL-10 as a lung inflammatory marker immediately after birth (basal) then 12 hours after birth (follow up).
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
El Dakahlya
-
Mansoura, El Dakahlya, Egypt, 35111
- Mansoura University Children Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Preterm infants with gestational age ≤ 32 weeks' gestation, presented with respiratory distress syndrome at birth
Exclusion Criteria:
- - Preterm infants with no manifestations of respiratory distress syndrome at birth.
- - Presence of major congenital malformation (dysmorphic features or anomalies incompatible with life) .
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Infants in this group will not receive sustained lung inflation in the delivery room and will be put immediately on CPAP at a pressure of 5 cm H2O.
|
|
|
Active Comparator: High pressure for long duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
|
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
|
|
Active Comparator: High pressure for short duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
|
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
|
|
Active Comparator: Low pressure for long duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
|
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
|
|
Active Comparator: Low pressure for short duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
|
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The need for endotracheal intubation in the delivery room
Time Frame: One hour
|
One hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The need for mechanical ventilation
Time Frame: 72 hours
|
72 hours
|
|
|
Need of surfactant
Time Frame: 72 hours
|
72 hours
|
|
|
Neonatal mortality
Time Frame: 90 days
|
Death before hospital discharge
|
90 days
|
|
Broncho Pulmonary Dysplasia ( BPD )
Time Frame: 90 days
|
Requirement for oxygen therapy more than 30% by 36 weeks corrected gestational age
|
90 days
|
|
Intra-Ventricular Hemorrhage ( IVH )
Time Frame: 14 days
|
14 days
|
|
|
Retinopathy of Prematurity ( ROP )
Time Frame: 50 days
|
50 days
|
|
|
Necrotizing Entero Colitis ( NEC )
Time Frame: 40 days
|
40 days
|
|
|
Length of neonatal intensive care ( NICU ) and hospital stay
Time Frame: 90 days
|
90 days
|
|
|
Air-leak syndrome
Time Frame: 14 days
|
Development of pneumothorax or pneumomediastinum
|
14 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NICU MUCH 2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome
-
PT. Prodia Stem Cell IndonesiaRumah Sakit Pusat Angkatan Darat Gatot SoebrotoRecruitingAcute Respiratory Distress SyndromeIndonesia
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruiting
-
Changchun Tuohua Pharmaceutical Co., Ltd.RecruitingAcute Respiratory Distress SyndromeChina
-
Southeast University, ChinaRecruitingAcute Respiratory Distress SyndromeChina
-
Southeast University, ChinaRecruitingAcute Respiratory Distress SyndromeChina
-
Ramos Mejía HospitalUniversidad de la RepublicaNot yet recruitingRespiratory Distress Syndrome (RDS)
-
Fayoum UniversityNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Ain Shams UniversityRecruitingAcute Respiratory Distress Syndrome (ARDS)Egypt
-
The Fourth Affiliated Hospital of Zhejiang University...Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
Clinical Trials on Sustained lung inflation in preterms (SLI).
-
University of FlorenceUnknownRespiratory Distress SyndromeItaly
-
Ain Shams UniversityCompletedRDS of Prematurity
-
Zekai Tahir Burak Women's Health Research and Education...UnknownRespiratory Distress Syndrome
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...WithdrawnLung Diseases | Preterm Birth | Respiratory Distress Syndrome
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome, NewbornEgypt